# Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Source: https://onco.cc/trials/nct07160686/  
OnCo record `nct07160686` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by University of Birmingham, not yet recruiting.

## Summary

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment is a phase 3, randomised interventional study registered as NCT07160686 by University of Birmingham, with a registry enrolment figure of 1456 participants, started 2026-03-02 and due to reach its primary completion in 2029-09-30. Interventions recorded: Apixaban; Placebo. Conditions listed: Thromboprophylaxis. Primary outcome: 18.3.1.1 Objectively confirmed VTE. Lung eligibility wording from the registry: "* Newly diagnosed locally advanced or metastatic primary lung cancer (histologically/ cytologically confirmed) or disease progression after complete or partial remission commencing a new course of SACT alone or as CRT". Sites: United Kingdom. United Kingdom sites listed: 1. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Also known as: THROMBO-STOP
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07160686
- Phase: 3
- Setting: A Phase III, Multicentre, Double Blind, Placebo-Controlled, Randomised Clinical Trial of Apixaban THROMBOprophylaxiS TO Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment
- Sponsor: University of Birmingham
- Enrolled: 1456

## Notes

- UK sites (registry): University of Birmingham (Birmingham).

## Sources

- ClinicalTrials.gov NCT07160686: https://clinicaltrials.gov/study/NCT07160686

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07160686.json